Bristol-Myers Squibb Company
Explore Bristol-Myers Squibb Company
Core profile pages, annual revenue records, and related research hubs for this company.
CorpDigest
Bristol-Myers Squibb Company
Explore Bristol-Myers Squibb Company
Core profile pages, annual revenue records, and related research hubs for this company.
Annual Revenue
FY2023 Revenue
$45.9B
▼ 0.4% vs FY2022 ($46.1B)
Source: Annual report / company filing
Bristol-Myers Squibb Company reported $45.9B in revenue for fiscal year 2023. This represents a decline of 0.4% compared to the 2022 figure of $46.1B. In 2024, revenue declined to $45.0B.
Revenues edged down 0.4% to $45.9 billion as generic erosion of Revlimid offset contributions from the Eliquis cardiovascular franchise and the Opdivo immuno-oncology portfolio.
| Year | Revenue | Net Income | YoY Change |
|---|---|---|---|
| FY2025 | $48.2B | — | +7.1% |
| FY2024 | $45.0B | $2.9B | -2.0% |
| FY2023 | $45.9B | — | -0.4% |
| FY2022 | $46.1B | — | — |
Source: SEC EDGAR filings, annual earnings releases, and verified financial disclosures.